| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |